Mild Cognitive Impairment (MCI) Clinical Trial
Official title:
Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms
NCT number | NCT02110043 |
Other study ID # | LOCATO-MCI-tDCS |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2014 |
Est. completion date | October 2017 |
Verified date | May 2021 |
Source | Charite University, Berlin, Germany |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to investigate whether a combination of intensive training of visual-spatial abilities (LOCATO task) with anodal transcranial direct current stimulation (tDCS) leads to an improvement in learning and memory in patients with mild cognitive impairment (MCI) and to examine the underlying neuronal mechanism.
Status | Completed |
Enrollment | 21 |
Est. completion date | October 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 90 Years |
Eligibility | Inclusion Criteria (MCI patients): - right handedness - amnestic and amnestic plus MCI with: 1. subjective memory impairment; 2. objective memory difficulties, at least 1 SD below gender, age and education adjusted standard values; 3. relatively normal performance in other cognitive domains; 4. no constraints in activities of daily livings 5. age: 50-90 years Exclusion Criteria: - severe internal or psychiatric disease - epilepsy - other severe neurological diseases, e.g. previous major stroke or brain tumor - DMS-IV manifest dementia - contraindication for MRT (claustrophobia, metallic implants, tattoos) |
Country | Name | City | State |
---|---|---|---|
Germany | Charite Universitätsmedizin Berlin | Berlin |
Lead Sponsor | Collaborator |
---|---|
Charite University, Berlin, Germany |
Germany,
Külzow N, Kerti L, Witte VA, Kopp U, Breitenstein C, Flöel A. An object location memory paradigm for older adults with and without mild cognitive impairment. J Neurosci Methods. 2014 Nov 30;237:16-25. doi: 10.1016/j.jneumeth.2014.08.020. Epub 2014 Aug 28. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Performance in LOCATO task (Visual-spatial learning and memory) after a combination of intensive visual-spatial training and tDCS | Investigation whether the combination of intensive visual-spatial training (LOCATO task) and tDCS leads to improvement of visual-spatial learning and memory measured by performance in LOCATO task after end of a 3 day period of training compared to sham stimulation. | immediately after end of a 3-day period of training in tDCS condition vs sham condition | |
Secondary | long term effects | long term effects measured by performance in LOCATO task in tDCS condition after end of cognitve training and after 1 month compared to control conditions | after 1 month vs baseline | |
Secondary | functional changes: Connectivity | Connectivity (measured by resting-state fMRT and correlation analysis) at baseline compared to end of 3 day period of training | end of 3-day cognitive training vs baseline | |
Secondary | cortical excitability | cortical excitability measured by transcranial magnetic stimulation (TMS) | at baseline | |
Secondary | Quality of Life | quality of life as measured by standardized questionaire at baseline compared to quality of life measured 1 month after intervention (training and stimulation vs. training and sham-stimualtion) | after 1 month vs baseline | |
Secondary | memory | memory performance tested at baseline compared to memory performance after the end of a 3-day cognitive training period and after 1 month (posttraining) in training and stimulation vs. training and sham stimulation | immediately after end of 3-day of cognitive training, after 1 month vs. baseline | |
Secondary | affective state | affective state measured at baseline compared to affective state measured after the end of a 3-day cognitve training period and after 1 month (posttraining) in training and stimulation vs. training and sham stimulation | immediately after the end of 3-day cognitive training, after 1 month vs. baseline | |
Secondary | genotyping of learning related polymorphisms | To assess predictors of positive reaction to brain stimulation, genotyping of several learning related polymorphisms will be performed (i.e., APOE, BDNF Val66Met, COMT Val158Met). | once |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00934531 -
Donepezil and the Risk of Falls in Seniors With Cognitive Impairment
|
N/A | |
Withdrawn |
NCT05033912 -
A Study of CST-2032 in Subjects With Cognitive Impairment
|
Phase 1 | |
Recruiting |
NCT02854033 -
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
|
||
Completed |
NCT01902004 -
Brain Aging and Treatment Response in Geriatric Depression
|
Phase 4 | |
Completed |
NCT01212692 -
Effects of Mental Stimulation in Patients With Mild Cognitive Impairment
|
Phase 2 | |
Recruiting |
NCT00544791 -
The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment
|
Phase 2 | |
Withdrawn |
NCT04055532 -
Biomarkers in Neurodegenerative Diseases
|
||
Terminated |
NCT02180529 -
The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment
|
N/A | |
Completed |
NCT05108922 -
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)
|
Phase 3 | |
Recruiting |
NCT05865340 -
To Exam the Efficacy of Oral Health and Mediterranean Diet Interventions in Preventing Cognitive Decline Among Older Adults With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT06453941 -
Yizhi Baduanjin for Patients With Cognitive Impairment
|
N/A | |
Completed |
NCT06417034 -
Hand Training Device For Cognitive Care
|
N/A | |
Completed |
NCT01383161 -
18-Month Study of Memory Effects of Curcumin
|
Phase 2 | |
Completed |
NCT01299766 -
Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment
|
Phase 3 | |
Withdrawn |
NCT05321498 -
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
|
Phase 2 | |
Completed |
NCT04748666 -
PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia
|
N/A | |
Recruiting |
NCT03138018 -
Aging Stereotypes and Prodromal Alzheimer's Disease
|
N/A | |
Withdrawn |
NCT01891383 -
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
|
||
Recruiting |
NCT03448055 -
Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health
|
N/A | |
Completed |
NCT01231971 -
Alzheimer's Disease Neuroimaging Initiative 2
|